her2- and met-mutation/amplification therapies
Published 5 years ago • 410 plays • Length 4:07
Download video MP4
Download video MP3
Similar videos
-
21:10
targeting her2, braf, kras, met
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
5:41
understanding nsclc treatments for less common mutations: alk, braf, ros1, her2, met
-
4:20
pik3ca mutations in her2-positive breast cancer
-
5:49
targeting her2 mutations in nsclc: what do we know?
-
2:23
the impact of her2 amplification in colorectal cancer
-
14:45
potential and progress in targeting less common markers: her2, braf, kras, met, trk, and ret
-
22:50
targeting her2, braf, kras, met, trk
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
32:30
chairperson perspective: precision payloads: exploring adc-directed therapies in her2-mutant and ...
-
6:00
case based panel discussions - egfr mutation & met - treatment decisions, level of met amplification
-
17:15
her2 targeted therapy for treatment of nsclc
-
3:59
her2 mutations in breast cancer
-
2:54
her2 mutation positive nsclc
-
12:44
dr manshi sharma | selection of 1st line therapy for met amplification and met exon 14 mutation
-
1:10
dr. drilon on met-amplified lung cancer
-
58:30
the potential of her2-, her3-, and trop2-targeted therapies to address unmet needs in advanced nsclc
-
3:45
evolving landscape of her2-targeted therapy in breast cancer
-
4:46
her2 mutations in cancer
Clip.africa.com - Privacy-policy